- Home
- Solutions
- Site & Patient Solutions
- Site & patient obesity solutions
Strategic site & patient obesity solutions
Accelerating obesity research with speed, scale & pre-identified patients
At ICON, we understand the complexities of obesity research — from regulatory pressure to enrolment challenges. The ICON Centre for Obesity is purpose-built to deliver faster, smarter, and more efficient trials, reducing operational risk while maximising patient access.
-
100 sites
ready-to-go -
10k patients
pre-screened database in development -
85% sites
operate on the same integrated technology platform
Broad access to the right patients
ICON’s obesity network spans 100 sites covering 75% of the US population and key international regions. With an in-development database of 10,000 pre-screened patients across the breadth of comorbidities, we connect you to your target patient population faster.
Rapid site startup & activation
We accelerate timelines with a turnkey approach:
- Master agreements in place
- Pre-collected regulatory documentation
- Obesity-specific site training
- Established imaging partnerships
-
30 days or less
This infrastructure enables site activation in 30 days or less, reducing trial startup risk and keeping your program on track.
Focused recruitment, real-time adaptability
Our recruitment strategy targets a wide range of obesity-related risk factors and comorbidities. We adapt to evolving study needs in real time to optimise enrolment — helping you avoid delays and ensure representative participation across all trial phases.
Integrated technology that drives efficiency
85% of our sites operate on the same CTMS/eSource, enabling:
- More efficient, interoperable processes in study recruitment and enrolment
- Real-time monitoring
- Remote data capture
- Fewer site errors
- Lower operational and travel costs
Our tech-enabled model enhances oversight, improves data quality, and supports rapid decision-making across your study.
Benefits for study sites:
Access to pre-screened patient pool to reduce recruitment time
Exclusivity in local metro areas and access to multiple obesity studies
Participate in multiple studies under one CDA and contract for greater efficiency and lower burden
Achieve site initiation visit readiness within 30 days with pre-completed core training and system registration
Innovative technology solutions to streamline patient lead conversion, reduce manual entry, and enhance data quality with centrally built eSource tools
Partner with ICON to accelerate your obesity research program
Whether you’re advancing early-phase research or scaling a global registration trial, ICON provides you with the infrastructure, insight, and innovation to move with confidence — from first patient in, to final data submission.
In this section
- Asset Development Consulting
-
Blended Solutions
-
Cardiac Safety Solutions
-
Clinical & Scientific Operations
-
Accelerated study start-up
-
Biostatistics and programming
- Clinical Operations
-
Data Monitoring Committee Services
-
Clinical Supplies Management
- COVID-19
- Clinical data science
-
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
-
Medical Affairs
-
Medical Call Centre Services
-
Medical Writing & Publishing
- Pharmacovigilance
-
Project and Program Management
-
Accelerated study start-up
- Commercial Positioning
- Decentralised Clinical Trials
-
Early Clinical
-
Accelerated Pharmaceutical Solutions
-
Bioanalytical Laboratories
-
Biometrics
-
Clinical Pharmacology
-
Clinical Research Facilities
-
Early Phase Oncology
-
Early Phase Patient Studies
-
Early Phase Obesity Trials
-
Quality and Compliance
-
TQT studies
-
Quantitative Pharmacology and Pharmacometrics
-
Volunteer Recruitment
-
Accelerated Pharmaceutical Solutions
- Language Services
-
Laboratories
- Medical Imaging
- Outcome Measures
- Real World Intelligence
- Regulatory Affairs
- Symphony Health data
- Site & Patient Solutions
-
Strategic Solutions
-
Technologies